Moreover, several reports showed that several parameters specific for RA such as rheumatoid factor (RF), anti-cyclic citrullinated peptide (ACPA), Health Assessment Questionnaire (HAQ), steroid use, methotrexate, and bDMARDs are associated with BMD in RA patients [12–15]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.